Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 MDI versus Seretide DPI on small airways markers in adult asthma
2006-000512-25Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate, formoterol, salmeterol + fluticasone, salmeterol and fluticasone propionate in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Functional parameters of the small airways and Inflammatory markers of the small airways. Started Jul 2007; status: completed.
02
Drugs
beclomethasone dipropionateformoterolsalmeterol + fluticasonesalmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000512-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000512-25.